Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Medication Therapy Management Empowerment Act of 2013
Client: WALGREEN CO · Firm: BLANK ROME GOVERNMENT RELATIONS
S. 557 and H.R. 1024 - the "Medication Therapy Management Empowerment Act" H.R. 4190 - To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Medication Therapy Management Empowerment Act of 2013
Client: WALGREEN CO · Firm: BLANK ROME GOVERNMENT RELATIONS
S. 557 and H.R. 1024 - the "Medication Therapy Management Empowerment Act" H.R. 4190 - To amend Title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
WALGREEN CO via BLANK ROME GOVERNMENT RELATIONS
2014 · fourth_quarter · 4T
H.R. 4190 - To amend Title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Issues relating to tax reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| GREAT CANADIAN RAILTOUR CO. LTD. |
| 10 |
| 2011–2014 |
| WALGREEN CO | 10 | 2012–2014 |
| FRANKLIN INSTITUTE | 9 | 2007–2009 |
| INTRADO | 9 | 2003–2007 |
| BWX TECHNOLOGIES INC | 8 | 2009–2014 |
| PHILADELPHIA MURAL ARTS ADVOCATES | 8 | 2010–2012 |
| AKER PHILADELPHIA SHIPYARD | 7 | 2009–2010 |
| NATIONAL ASSOCIATION FOR FIXED ANNUITIES | 7 | 2009–2010 |
| UNIVERSITY OF PITTSBURGH | 7 | 2004–2007 |
| PRUDENTIAL FINANCIAL INC | 6 | 2005–2013 |
| APPLIED ENERGETICS (FORMERLY IONATRON) | 5 | 2003–2005 |
| ARAMARK | 5 | 2005–2007 |
| BANYAN COMMUNICATIONS | 5 | 2008 |
| BRACCO DIAGNOSTICS INC. | 5 | 2005–2007 |
| CANADIAN STANDARDS ASSOCIATION | 5 | 2014 |
| DESTINY USA | 5 | 2003–2005 |
| EMC CORP | 5 | 2006–2011 |
| FORTRESS TECHNOLOGIES, INC. | 5 | 2005–2007 |
| MOBILITY TECHNOLOGIES INC | 5 | 2003–2005 |
| NATIONAL MUSEUM OF AMERICAN JEWISH HISTORY | 5 | 2006–2008 |
| PUBLIC INTELLIGENCE INC | 5 | 2003–2004 |
| SAP PUBLIC SERVICES INC | 5 | 2003–2006 |
| SITA INC | 5 | 2004–2006 |
| SMOKE FREE ALTERNATIVES TRADE ASSOCIATION | 5 | 2014 |
| DIVERSIFIED INFORMATION TECHNOLOGIES INC | 4 | 2003–2005 |
| GAS PROCESSORS ASSOCIATION | 4 | 2013–2014 |
| HEALTH INDUSTRY DISTRIBUTERS ASSOCIATION | 4 | 2014 |
| PHILADELPHIA HOLOCAUST REMEMBRANCE FOUNDATION | 4 | 2006–2007 |
| RAJANT CORPORATION | 4 | 2003–2004 |
| TELE ATLAS | 4 | 2006–2007 |
| TUTOR OUR CHILDREN LLC | 4 | 2010–2011 |
| URS CORPORATION | 4 | 2003–2004 |
| ADVANCED PROGRAMS | 3 | 2003 |
| AERIALS EXPRESS | 3 | 2003–2004 |
| ALUMINUM CHAMBERED BOATS INC | 3 | 2008 |
| AMERICAN CRUISE LINES, INC. | 3 | 2013 |
| BEN FRANKLIN TECHNOLOGY PARTNERS | 3 | 2005–2007 |
| BOEING CO | 3 | 2003–2005 |
| BORLAND SOFTWARE CORPORATION | 3 | 2004–2005 |
| FERUS, INC. | 3 | 2011–2012 |
| LEIDOS | 3 | 2014 |
| SAN DIEGO ASSOCIATION OF GOVERNMENTS | 3 | 2006 |
| SAP AMERICA INC. | 3 | 2006 |
| STRIKEFORCE TECHNOLOGIES | 3 | 2004–2005 |
| THE HERSHEY COMPANY | 3 | 2011 |
| ALISOS INSTITUTE | 2 | 2003–2004 |
| BEST BUY | 2 | 2014 |
| COLLABORATIVE FUSION | 2 | 2004 |
| FACTICAN INC | 2 | 2003–2004 |
| FISHER SCIENTIFIC COMPANY | 2 | 2003 |
| FONTAINE INC | 2 | 2005 |
| GRANT & ASSOC JAY | 2 | 2004–2005 |
| HOMELAND SECURITY CORP | 2 | 2003–2004 |
| INTL BARCODE CORP | 2 | 2001–2005 |
| LIBERTY MARITIME CORPORATION | 2 | 2012 |
| NAVIGANT CONSULTING | 2 | 2003–2004 |
| PENNROSE PROPERTIES | 2 | 2003 |
| PITTSBURGH DIGITAL GREENHOUSE | 2 | 2003 |
| SELECT GREATER PHILADELPHIA (FORMERLY LISTED AS THE CEO COUNCIL FOR GROWTH) | 2 | 2012 |
| SILICON GRAPHICS | 2 | 2004 |
| T-MOBILE | 2 | 2014 |
| 20/20 GENESYSTEMS, INC. | 1 | 2003 |
| ADH HEALTH PRODUCTS | 1 | 2003 |
| CARNEGIE MELLON UNIV | 1 | 2004 |
| COMCAST CORPORATION | 1 | 2010 |
| CUSHMAN & WAKEFIELD | 1 | 2004 |
| GEO GROUP | 1 | 2005 |
| MASCARO CONSTRUCTION COMPANY LP | 1 | 2003 |
| MASTEC | 1 | 2003 |
| MOTOROLA SOLUTIONS | 1 | 2013 |
| NCO GROUP | 1 | 2003 |
| RANBAXY LABORATORIES | 1 | 2005 |
| SIGA TECHNOLOGIES, INC. | 1 | 2005 |
| THOMAS M COOLEY LAW SCHOOL | 1 | 2005 |
| TRANSCORE | 1 | 2003 |
| TRIANGLE LIFE SCIENCES LLC | 1 | 2003 |
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Master Limited Partnerships Parity Act
Client: REPUBLIC SERVICES · Firm: BLANK ROME GOVERNMENT RELATIONS
Issues related to renewable energy and natural gas tax incentives S. 795/H.R. 1696: The Master Limited Partnerships Parity Act
Safeguarding America's Pharmaceuticals Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Safeguarding America's Pharmaceuticals Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Safeguarding America's Pharmaceuticals Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Safeguarding America's Pharmaceuticals Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Safeguarding America's Pharmaceuticals Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
School Access to Emergency Epinephrine Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
School Access to Emergency Epinephrine Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
School Access to Emergency Epinephrine Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
School Access to Emergency Epinephrine Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
School Access to Emergency Epinephrine Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Coal Residuals Reuse and Management Act of 2013
Client: REPUBLIC SERVICES · Firm: BLANK ROME GOVERNMENT RELATIONS
Issues related to waste management H.R. 2218: The Coal Residuals Reuse and Management Act of 2013
Internet Tax Freedom Act (H.R. 3086)
Internet Tax Freedom Act (H.R. 3086)
PEPFAR Stewardship and Oversight Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
PEPFAR Stewardship and Oversight Act of 2013 (S. 1545 / H.R. 3177)
To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Client: WALGREEN CO · Firm: BLANK ROME GOVERNMENT RELATIONS
S. 557 and H.R. 1024 - the "Medication Therapy Management Empowerment Act" H.R. 4190 - To amend Title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Client: WALGREEN CO · Firm: BLANK ROME GOVERNMENT RELATIONS
S. 557 and H.R. 1024 - the "Medication Therapy Management Empowerment Act" H.R. 4190 - To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Client: WALGREEN CO · Firm: BLANK ROME GOVERNMENT RELATIONS
H.R. 4190 - To amend Title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Client: WALGREEN CO · Firm: BLANK ROME GOVERNMENT RELATIONS
H.R. 4190 - To amend Title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Protecting Access to Medicare Act of 2014
Client: WALGREEN CO · Firm: BLANK ROME GOVERNMENT RELATIONS
Issues relating to the Sustainable Growth Rate (SGR) (H.R. 4302)
Travel Promotion, Enhancement, and Modernization Act of 2014
Client: EXPEDIA, INC. · Firm: BLANK ROME GOVERNMENT RELATIONS
Consumer issues H.R. 4450, S. 2250 Travel Promotion, Enhancement, and Modernization Act
Travel Promotion, Enhancement, and Modernization Act of 2014
Client: EXPEDIA, INC. · Firm: BLANK ROME GOVERNMENT RELATIONS
Consumer issues H.R. 4450, S. 2250 Travel Promotion, Enhancement, and Modernization Act
Patients' Access to Treatments Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Patients' Access to Treatments Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Patients' Access to Treatments Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Patients' Access to Treatments Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Patients' Access to Treatments Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Stop Tampering of Prescription Pills Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Stop Tampering of Prescription Pills Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Stop Tampering of Prescription Pills Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Stop Tampering of Prescription Pills Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Stop Tampering of Prescription Pills Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Issues related to sales tax fairness legislation, The Marketplace Fairness Act (H.R. 684, S.336, S.743)
Issues related to sales tax fairness legislation, The Marketplace Fairness Act (H.R. 684, S.336, S.743)
Patent Abuse Reduction Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Patent Abuse Reduction Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Patent Abuse Reduction Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Patent Abuse Reduction Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
S. 214, Preserve Access to Affordable Generics Act S. 1720, Patent Transparency and Improvements Act of 2013 S. 1013, Patent Abuse Reduction Act of 2013
PEPFAR Stewardship and Oversight Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
PEPFAR Stewardship and Oversight Act of 2013 (S. 1545 / H.R. 3177)
Patent Transparency and Improvements Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Patent Transparency and Improvements Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Patent Transparency and Improvements Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Patent Transparency and Improvements Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
S. 214, Preserve Access to Affordable Generics Act S. 1720, Patent Transparency and Improvements Act of 2013 S. 1013, Patent Abuse Reduction Act of 2013
Preserve Access to Affordable Generics Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
S. 214, Preserve Access to Affordable Generics Act S. 1720, Patent Transparency and Improvements Act of 2013 S. 1013, Patent Abuse Reduction Act of 2013
Preserve Access to Affordable Generics Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
S. 214, Preserve Access to Affordable Generics Act
Preserve Access to Affordable Generics Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Preserve Access to Affordable Generics Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Preserve Access to Affordable Generics Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Travel Promotion, Enhancement, and Modernization Act of 2014
Client: EXPEDIA, INC. · Firm: BLANK ROME GOVERNMENT RELATIONS
Consumer issues H.R. 4450, S. 2250 Travel Promotion, Enhancement, and Modernization Act
Travel Promotion, Enhancement, and Modernization Act of 2014
Client: EXPEDIA, INC. · Firm: BLANK ROME GOVERNMENT RELATIONS
Consumer issues H.R. 4450, S. 2250 Travel Promotion, Enhancement, and Modernization Act
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2015
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Issues related to sales tax fairness legislation, The Marketplace Fairness Act (H.R. 684, S.336, S.743)
Issues related to sales tax fairness legislation, The Marketplace Fairness Act (H.R. 684, S.336, S.743)
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Medication Therapy Management Empowerment Act of 2013
Client: WALGREEN CO · Firm: BLANK ROME GOVERNMENT RELATIONS
S. 557 and H.R. 1024 - the "Medication Therapy Management Empowerment Act" H.R. 4190 - To amend Title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Medication Therapy Management Empowerment Act of 2013
Client: WALGREEN CO · Firm: BLANK ROME GOVERNMENT RELATIONS
S. 557 and H.R. 1024 - the "Medication Therapy Management Empowerment Act" H.R. 4190 - To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Safe Prescribing Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Safe Prescribing Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Safe Prescribing Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Safe Prescribing Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Safe Prescribing Act of 2013
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Energy Savings and Industrial Competitiveness Act of 2013
Client: CANADIAN STANDARDS ASSOCIATION · Firm: BLANK ROME GOVERNMENT RELATIONS
Issues relating to the Energy Savings and Industrial Competitiveness (ESIC) Act (S. 761)
Energy Savings and Industrial Competitiveness Act of 2013
Client: CANADIAN STANDARDS ASSOCIATION · Firm: BLANK ROME GOVERNMENT RELATIONS
Issues relating to the Energy Savings and Industrial Competitiveness (ESIC) Act (S. 761)
Energy Savings and Industrial Competitiveness Act of 2013
Client: CANADIAN STANDARDS ASSOCIATION · Firm: BLANK ROME GOVERNMENT RELATIONS
Issues relating to the Energy Savings and Industrial Competitiveness (ESIC) Act (S. 761)
Master Limited Partnerships Parity Act
Client: REPUBLIC SERVICES · Firm: BLANK ROME GOVERNMENT RELATIONS
Issues related to renewable energy and natural gas tax incentives S. 795/H.R. 1696: The Master Limited Partnerships Parity Act
Medicare Prescription Drug Program Integrity and Transparency Act of 2013
Client: WALGREEN CO · Firm: BLANK ROME GOVERNMENT RELATIONS
S. 867 - Issues related to Pharmacy Benefit Managers (PBM) activities around disclosures and audit protections.
Drug Supply Chain Security Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Drug Supply Chain Security Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Drug Supply Chain Security Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Drug Supply Chain Security Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Drug Supply Chain Security Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Pharmaceutical Quality, Security, and Accountability Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Pharmaceutical Quality, Security, and Accountability Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Pharmaceutical Quality, Security, and Accountability Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Pharmaceutical Quality, Security, and Accountability Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
Pharmaceutical Quality, Security, and Accountability Act
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
American Taxpayer Relief Act of 2012
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
American Taxpayer Relief Act of 2012
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
American Taxpayer Relief Act of 2012
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
American Taxpayer Relief Act of 2012
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
American Taxpayer Relief Act of 2012
Client: MYLAN LABORATORIES INC · Firm: BLANK ROME GOVERNMENT RELATIONS
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
2014 · fourth_quarter · 4T
Internet Tax Freedom Act (H.R. 3086)
Filing targets: SENATE
SMOKE FREE ALTERNATIVES TRADE ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · fourth_quarter · 4T
Issues relating to the regulation of vapor products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REPUBLIC SERVICES via BLANK ROME GOVERNMENT RELATIONS
2014 · fourth_quarter · 4T
Issues related to tax extenders and the taxation of renewable energy
Issues relating to renewable energy and waste management
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MYLAN LABORATORIES INC via BLANK ROME GOVERNMENT RELATIONS
2014 · fourth_quarter · 4T
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
General tax issues Issues related to corporate inversions
US policy with respect to India Implementing PEPFAR Stewardship and Oversight Act of 2013
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTH INDUSTRY DISTRIBUTERS ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · fourth_quarter · 4T
Issues relating to the distribution of health care products Issues relating to competitive bidding and pharmaceutical pedigree 21st Century Cures initiative; Medical device licensure legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXPEDIA, INC. via BLANK ROME GOVERNMENT RELATIONS
2014 · fourth_quarter · 4T
Issues related to the disclosure of airline fees Issues related to the disclosure of transportation fees
Consumer issues H.R. 4450, S. 2250 Travel Promotion, Enhancement, and Modernization Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANADIAN STANDARDS ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · fourth_quarter · 4T
Issues related to railroad safety
Filing targets: HOUSE OF REPRESENTATIVES
BEST BUY via BLANK ROME GOVERNMENT RELATIONS
2014 · fourth_quarter · 4T
Issues related to sales tax fairness legislation, The Marketplace Fairness Act (H.R. 684, S.336, S.743)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXPEDIA, INC. via BLANK ROME GOVERNMENT RELATIONS
2014 · third_quarter · Q3
Consumer issues H.R. 4450, S. 2250 Travel Promotion, Enhancement, and Modernization Act
Issues related to the disclosure of airline fees Issues related to the disclosure of transportation fees
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN CO via BLANK ROME GOVERNMENT RELATIONS
2014 · third_quarter · Q3
Issues relating to tax reform and corporate inversions
H.R. 4190 - To amend Title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
T-MOBILE via BLANK ROME GOVERNMENT RELATIONS
2014 · third_quarter · Q3
Internet Tax Freedom Act (H.R. 3086)
Filing targets: SENATE
LEIDOS via BLANK ROME GOVERNMENT RELATIONS
2014 · third_quarter · Q3
FY 2015 Military Construction-VA Appropriations, including information technology funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REPUBLIC SERVICES via BLANK ROME GOVERNMENT RELATIONS
2014 · third_quarter · Q3
Issues related to tax extenders and the taxation of renewable energy
Issues relating to renewable energy and waste management
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTH INDUSTRY DISTRIBUTERS ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · third_quarter · Q3
Issues relating to the distribution of health care products Issues relating to competitive bidding and pharmaceutical pedigree
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANADIAN STANDARDS ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · third_quarter · Q3
Issues related to railroad safety
Filing targets: HOUSE OF REPRESENTATIVES
BEST BUY via BLANK ROME GOVERNMENT RELATIONS
2014 · third_quarter · Q3
Issues related to sales tax fairness legislation, The Marketplace Fairness Act (H.R. 684, S.336, S.743)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMOKE FREE ALTERNATIVES TRADE ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · third_quarter · Q3
Issues relating to the regulation of vapor products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MYLAN LABORATORIES INC via BLANK ROME GOVERNMENT RELATIONS
2014 · third_quarter · Q3
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
US policy with respect to India Implementing PEPFAR Stewardship and Oversight Act of 2013
SMOKE FREE ALTERNATIVES TRADE ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · Q2
Issues relating to the regulation of vapor products
Issues related to the taxation of vapor products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GAS PROCESSORS ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · Q2
Issues relating to natural gas Water Resources Development Act (S. 601 / H.R. 3080) Issues related to proposed regulations of the U.S. Fish & Wildlife Service (USFWS) related to the long eared bat
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Fish & Wildlife Service (USFWS)
WALGREEN CO via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · Q2
S. 557 and H.R. 1024 - the "Medication Therapy Management Empowerment Act" H.R. 4190 - To amend Title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
Issues relating to tax reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MYLAN LABORATORIES INC via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · 2A
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Implementation of PEPFAR Stewardship and Oversight Act of 2013
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013; House Energy & Commerce Committee's 21st Century Cures initiative
CANADIAN STANDARDS ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · Q2
Issues related to high speed rail transportation and security
Filing targets: HOUSE OF REPRESENTATIVES
HEALTH INDUSTRY DISTRIBUTERS ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · Q2
Issues relating to excise tax on medical devices
Issues relating to the distribution of health care products Issues relating to competitive bidding and pharmaceutical pedigree
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REPUBLIC SERVICES via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · Q2
Issues related to tax extenders and the taxation of renewable energy
Issues relating to renewable energy and waste management
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXPEDIA, INC. via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · Q2
Issues related to the disclosure of airline fees Issues related to the disclosure of transportation fees
Consumer issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LEIDOS via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · Q2
FY 2015 Labor/HHS Appropriations, funding for vaccine development; FY 2015 Defense Appropriations, Naval Health Research Center funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LEIDOS via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · RR
Issues relating to existing FY15 DOD and HHS federal budget line items
Issues relating to existing FY15 DOD and HHS federal budget line items
Issues relating to existing FY15 DOD and HHS federal budget line items
HEALTH INDUSTRY DISTRIBUTERS ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · second_quarter · RR
DMEPOS Competitive Bidding; Excise Tax on Medical Devices; Pharmaceutical Pedigree
REPUBLIC SERVICES via BLANK ROME GOVERNMENT RELATIONS
2014 · first_quarter · Q1
Issues related to waste management H.R. 2218: The Coal Residuals Reuse and Management Act of 2013
Issues related to renewable energy and natural gas tax incentives S. 795/H.R. 1696: The Master Limited Partnerships Parity Act
Issues relating to truck weights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXPEDIA, INC. via BLANK ROME GOVERNMENT RELATIONS
2014 · first_quarter · Q1
Consumer issues
Issues relating to occupancy tax
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BWX TECHNOLOGIES INC via BLANK ROME GOVERNMENT RELATIONS
2014 · first_quarter · 1A
Issues relating to DOE/NNSA procurement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MYLAN LABORATORIES INC via BLANK ROME GOVERNMENT RELATIONS
2014 · first_quarter · 1A
Implementation of PEPFAR Stewardship and Oversight Act of 2013
S. 214, Preserve Access to Affordable Generics Act S. 1720, Patent Transparency and Improvements Act of 2013 S. 1013, Patent Abuse Reduction Act of 2013
FY 2014 Appropriations; President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund; Generic Drug User Fees; Biosimilar User Fees; Funding for FDA; Funding for the Office of Generic Drugs; FY14 Presidential Budget Request
GREAT CANADIAN RAILTOUR CO. LTD. via BLANK ROME GOVERNMENT RELATIONS
2014 · first_quarter · 1T
Issues relating to DHS/CBP pre-clearance and inspections
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MYLAN LABORATORIES INC via BLANK ROME GOVERNMENT RELATIONS
2014 · first_quarter · Q1
S. 214, Preserve Access to Affordable Generics Act
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
FY 2014 Appropriations; President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund; Generic Drug User Fees; Biosimilar User Fees; Funding for FDA; Funding for the Office of Generic Drugs; FY14 Presidential Budget Request
GAS PROCESSORS ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · first_quarter · Q1
Issues relating to natural gas Water Resources Development Act (S. 601 / H.R. 3080)
Filing targets: HOUSE OF REPRESENTATIVES
WALGREEN CO via BLANK ROME GOVERNMENT RELATIONS
2014 · first_quarter · Q1
Issues relating to the Sustainable Growth Rate (SGR) (H.R. 4302)
Issues relating to tax reform
S. 557 and H.R. 1024 - the "Medication Therapy Management Empowerment Act" H.R. 4190 - To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services.
CANADIAN STANDARDS ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · first_quarter · Q1
Issues relating to the Energy Savings and Industrial Competitiveness (ESIC) Act (S. 761)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMOKE FREE ALTERNATIVES TRADE ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · first_quarter · Q1
Issues relating to the regulation of vapor products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMOKE FREE ALTERNATIVES TRADE ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · first_quarter · RR
Issues relating to the regulation of vapor products
CANADIAN STANDARDS ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2014 · first_quarter · RR
Issues relating to the Energy Savings and Industrial Competitiveness (ESIC) Act (S. 761)
Issues relating to the Energy Savings and Industrial Competitiveness (ESIC) Act (S. 761)
BWX TECHNOLOGIES INC via BLANK ROME GOVERNMENT RELATIONS
2014 · first_quarter · Q1
Issues relating to DOE/NNSA procurement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CRUISE LINES, INC. via BLANK ROME GOVERNMENT RELATIONS
2013 · fourth_quarter · 4A
Issues pertaining to overnight passenger cruise vessels H.R. 1961 / S. 1022 To amend title 46, United States Code, to extend the exemption from the fire-retardant materials construction requirement for vessels operating within the Boundary Line.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Coast Guard (USCG)
EXPEDIA, INC. via BLANK ROME GOVERNMENT RELATIONS
2013 · fourth_quarter · 4A
Issues relating to occupancy tax
Issues relating to patent litigation reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MYLAN LABORATORIES INC via BLANK ROME GOVERNMENT RELATIONS
2013 · fourth_quarter · 4A
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
FY 2014 Appropriations; President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund; Generic Drug User Fees; Biosimilar User Fees; Funding for FDA; Funding for the Office of Generic Drugs; FY14 Presidential Budget Request
REPUBLIC SERVICES via BLANK ROME GOVERNMENT RELATIONS
2013 · fourth_quarter · 4A
Issues related to renewable energy and natural gas tax incentives S. 795/H.R. 1696: The Master Limited Partnerships Parity Act
Issues relating to truck weights
Issues relating to bio-gas H.R. 1947: The Farm Bill, specifically Title IX, which provides funding for biofuels, energy-efficiency programs in rural areas, and the development of biochemicals and bioplastics industries. Issues relating to the renewable fuel standard
EXPEDIA, INC. via BLANK ROME GOVERNMENT RELATIONS
2013 · fourth_quarter · Q4
Issues relating to occupancy tax
Issues relating to patent litigation reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MYLAN LABORATORIES INC via BLANK ROME GOVERNMENT RELATIONS
2013 · fourth_quarter · Q4
S. 214, Preserve Access to Affordable Generics Act
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
FY 2014 Appropriations; President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund; Generic Drug User Fees; Biosimilar User Fees; Funding for FDA; Funding for the Office of Generic Drugs; FY14 Presidential Budget Request
REPUBLIC SERVICES via BLANK ROME GOVERNMENT RELATIONS
2013 · fourth_quarter · Q4
Issues related to waste management H.R. 2218: The Coal Residuals Reuse and Management Act of 2013
Pension Reform Issues
Issues relating to truck weights
EDISONLEARNING via BLANK ROME GOVERNMENT RELATIONS
2013 · fourth_quarter · 4T
Issues relating to education reform ESEA Reauthorization (H.R. 5)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GREAT CANADIAN RAILTOUR CO. LTD. via BLANK ROME GOVERNMENT RELATIONS
2013 · fourth_quarter · Q4
Issues relating to DHS/CBP pre-clearance and inspections
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
WALGREEN CO via BLANK ROME GOVERNMENT RELATIONS
2013 · fourth_quarter · Q4
Issues relating to the Sustainable Growth Rate (SGR). No specific legislation.
S. 867 - Issues related to Pharmacy Benefit Managers (PBM) activities around disclosures and audit protections.
S. 557 and H.R. 1024 - the "Medication Therapy Management Empowerment Act" S. 957 - Drug Supply Chain Security Act S. 959 - Pharmaceutical Quality, Security, and Accountability Act Issues related to related to pharmacists recognized as health care providers federally. No specific legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GAS PROCESSORS ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2013 · fourth_quarter · Q4
Issues relating to natural gas Water Resources Development Act (S. 601)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CRUISE LINES, INC. via BLANK ROME GOVERNMENT RELATIONS
2013 · fourth_quarter · Q4
Issues pertaining to overnight passenger cruise vessels H.R. 1961 / S. 1022 To amend title 46, United States Code, to extend the exemption from the fire-retardant materials construction requirement for vessels operating within the Boundary Line.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Coast Guard (USCG)
BWX TECHNOLOGIES INC via BLANK ROME GOVERNMENT RELATIONS
2013 · fourth_quarter · Q4
Issues relating to DOE/NNSA procurement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GAS PROCESSORS ASSOCIATION via BLANK ROME GOVERNMENT RELATIONS
2013 · fourth_quarter · RR
Issues relating to the natural gas industry
BWX TECHNOLOGIES INC via BLANK ROME GOVERNMENT RELATIONS
2013 · third_quarter · Q3
Issues related to Navy shipbuilding FY 2014 NDAA (H.R. 1960 and S. 1034) Issues relating to NNSA nomination FY 2014 DOD Appropriations
Issues related to Navy shipbuilding; DOD Budget; Sequestration; FY 2014 Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN CO via BLANK ROME GOVERNMENT RELATIONS
2013 · third_quarter · Q3
S. 867 - Issues related to Pharmacy Benefit Managers (PBM) activities around disclosures and audit protections.
S. 557 and H.R. 1024 - the "Medication Therapy Management Empowerment Act" Issues related to related to pharmacists recognized as health care providers federally. No specific legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXPEDIA, INC. via BLANK ROME GOVERNMENT RELATIONS
2013 · third_quarter · Q3
Issues relating to occupancy tax
Competition in the internet search market
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GREAT CANADIAN RAILTOUR CO. LTD. via BLANK ROME GOVERNMENT RELATIONS
2013 · third_quarter · Q3
Issues relating to DHS/CBP pre-clearance and inspections
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDISONLEARNING via BLANK ROME GOVERNMENT RELATIONS
2013 · third_quarter · Q3
Issues relating to education reform ESEA Reauthorization (H.R. 5)
Filing targets: HOUSE OF REPRESENTATIVES
AMERICAN CRUISE LINES, INC. via BLANK ROME GOVERNMENT RELATIONS
2013 · third_quarter · Q3
Issues pertaining to overnight passenger cruise vessels H.R. 1961 / S. 1022 To amend title 46, United States Code, to extend the exemption from the fire-retardant materials construction requirement for vessels operating within the Boundary Line.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Coast Guard (USCG)
REPUBLIC SERVICES via BLANK ROME GOVERNMENT RELATIONS
2013 · third_quarter · Q3
Issues related to waste management H.R. 2218: The Coal Residuals Reuse and Management Act of 2013
Issues relating to truck weights
Issues related to renewable energy and natural gas tax incentives S. 795/H.R. 1696: The Master Limited Partnerships Parity Act
MYLAN LABORATORIES INC via BLANK ROME GOVERNMENT RELATIONS
2013 · third_quarter · Q3
FY 2014 Appropriations; President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund; Generic Drug User Fees; Biosimilar User Fees; Funding for FDA; Funding for the Office of Generic Drugs; FY14 Presidential Budget Request
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
WALGREEN CO via BLANK ROME GOVERNMENT RELATIONS
2013 · second_quarter · Q2
S. 557 and H.R. 1024 - the "Medication Therapy Management Empowerment Act" Issues related to related to pharmacists recognized as health care providers federally. No specific legislation.
S. 867 - Issues related to Pharmacy Benefit Managers (PBM) activities around disclosures and audit protections.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MYLAN LABORATORIES INC via BLANK ROME GOVERNMENT RELATIONS
2013 · second_quarter · Q2
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
FY 2014 Appropriations and FY 2013 Appropriations; President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund; Generic Drug User Fees; Biosimilar User Fees; Funding for FDA; Funding for the Office of Generic Drugs; FY13 Presidential Budget Request
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BWX TECHNOLOGIES INC via BLANK ROME GOVERNMENT RELATIONS
2013 · second_quarter · Q2
Issues relating to DOE procurement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXPEDIA, INC. via BLANK ROME GOVERNMENT RELATIONS
2013 · second_quarter · Q2
Competition in the internet search market
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDISONLEARNING via BLANK ROME GOVERNMENT RELATIONS
2013 · second_quarter · Q2
Issues relating to education reform
Filing targets: HOUSE OF REPRESENTATIVES
GREAT CANADIAN RAILTOUR CO. LTD. via BLANK ROME GOVERNMENT RELATIONS
2013 · second_quarter · Q2
Issues related to pre-inspection clearance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REPUBLIC SERVICES via BLANK ROME GOVERNMENT RELATIONS
2013 · second_quarter · Q2
Pension Reform Issues
Issues relating to bio-gas H.R. 1947: The Farm Bill, specifically Title IX, which provides funding for biofuels, energy-efficiency programs in rural areas, and the development of biochemicals and bioplastics industries.
Issues relating to truck weights
MOTOROLA SOLUTIONS via BLANK ROME GOVERNMENT RELATIONS
2013 · second_quarter · Q2
Issues related to public safety/D block spectrum, cybersecurity
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN CO via BLANK ROME GOVERNMENT RELATIONS
2013 · first_quarter · Q1
Issues relating to authorizing states to require all sellers making remote sales to collect and remit sales and use taxes with respect to such sales into the state, without regard to the location of the seller. Issues related to corporate tax reform.
Issues related to expanding the eligibility of all targeted beneficiaries for access to Medication Therapy Management (MTM) in Medicare Part D. Issues related to the requirement of MTM services to include person-to-person targeted medication reviews by a licensed pharmacist offered at least every quarter and expand eligibility of all target beneficiaries for access to MTM.
REPUBLIC SERVICES via BLANK ROME GOVERNMENT RELATIONS
2013 · first_quarter · Q1
Issues related to renewable energy and natural gas tax incentives
Pension Reform Issues
Issues related to waste management and taxes
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MYLAN LABORATORIES INC via BLANK ROME GOVERNMENT RELATIONS
2013 · first_quarter · Q1
Issues related to generic drug industry; generic drug user fees; supply chain integrity; Hatch-Waxman exclusivity; prescription drug labeling; access to epinephrine auto-injectors; FDA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GREAT CANADIAN RAILTOUR CO. LTD. via BLANK ROME GOVERNMENT RELATIONS
2013 · first_quarter · Q1
Issues related to proposed rail route
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
EXPEDIA, INC. via BLANK ROME GOVERNMENT RELATIONS
2013 · first_quarter · Q1
Competition in the internet search market
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRUDENTIAL FINANCIAL INC via BLANK ROME GOVERNMENT RELATIONS
2013 · first_quarter · Q1
Issues and legislation relating to retirement security, ERISA
Issues related to implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act.
Issues relating to the debt ceiling
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIBERTY MARITIME CORPORATION via BLANK ROME GOVERNMENT RELATIONS
2012 · fourth_quarter · 4A
Maritime Security Program, cargo preference laws, and other related issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GAS TECHNOLOGY INSTITUTE via BLANK ROME GOVERNMENT RELATIONS
2012 · second_quarter · 2A
Issues related to natural gas and biodigesters
Filing targets: HOUSE OF REPRESENTATIVES
GAS TECHNOLOGY INSTITUTE via BLANK ROME GOVERNMENT RELATIONS
2012 · first_quarter · 1A
Issues related to natural gas and biodigesters
Filing targets: HOUSE OF REPRESENTATIVES
WALGREEN CO via BLANK ROME GOVERNMENT RELATIONS
2012 · fourth_quarter · Q4
Issues relating to pharmacy benefit managers and general business issues
Issues relating to pharmacy benefit managers and general business issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN CO via BLANK ROME GOVERNMENT RELATIONS
2012 · fourth_quarter · RR
Issues relating to pharmacy benefit managers and general business issues
Issues relating to pharmacy benefit managers and general business issues
EXPEDIA, INC. via BLANK ROME GOVERNMENT RELATIONS
2012 · fourth_quarter · Q4
Competition in the internet search market
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REPUBLIC SERVICES via BLANK ROME GOVERNMENT RELATIONS
2012 · fourth_quarter · Q4
Issues related to waste management and taxes
Issues related to renewable energy and natural gas tax incentives
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GREAT CANADIAN RAILTOUR CO. LTD. via BLANK ROME GOVERNMENT RELATIONS
2012 · fourth_quarter · Q4
Issues related to proposed rail route
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
EDISONLEARNING via BLANK ROME GOVERNMENT RELATIONS
2012 · third_quarter · Q3
Issues related to the Elementary and Secondary Education Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MYLAN LABORATORIES INC via BLANK ROME GOVERNMENT RELATIONS
2012 · fourth_quarter · Q4
Issues related to generic drug industry; generic drug user fees; supply chain integrity; Hatch-Waxman exclusivity; prescription drug labeling; access to epinephrine auto-injectors; FDA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIBERTY MARITIME CORPORATION via BLANK ROME GOVERNMENT RELATIONS
2012 · fourth_quarter · Q4
Maritime Security Program, cargo preference laws, and other related issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SELECT GREATER PHILADELPHIA (FORMERLY LISTED AS THE CEO COUNCIL FOR GROWTH) via BLANK ROME GOVERNMENT RELATIONS
2012 · fourth_quarter · Q4
Issues pertaining to business development and economic development in the Greater Philadelphia area
Issues regarding visas for workers in high-skilled fields.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GREAT CANADIAN RAILTOUR CO. LTD. via BLANK ROME GOVERNMENT RELATIONS
2012 · fourth_quarter · RA
Approval for pre-clearance of rail route across U.S.-Canadian border.
Approval for pre-clearance of rail route across U.S.-Canadian border.
Approval for pre-clearance of rail route across U.S.-Canadian border.
SELECT GREATER PHILADELPHIA (FORMERLY LISTED AS THE CEO COUNCIL FOR GROWTH) via BLANK ROME GOVERNMENT RELATIONS
2012 · third_quarter · Q3
Issues pertaining to business development and economic development in the Greater Philadelphia area
Filing targets: HOUSE OF REPRESENTATIVES
REPUBLIC SERVICES via BLANK ROME GOVERNMENT RELATIONS
2012 · third_quarter · Q3
Issues related to renewable energy and natural gas tax incentives
Issues related to waste management and coal ash
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MYLAN LABORATORIES INC via BLANK ROME GOVERNMENT RELATIONS
2012 · third_quarter · Q3
Issues related to generic drug industry; generic drug user fees; supply chain integrity; Hatch-Waxman exclusivity; prescription drug labeling; access to epinephrine auto-injectors; FDA
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXPEDIA, INC. via BLANK ROME GOVERNMENT RELATIONS
2012 · third_quarter · Q3
Competition in the internet search market
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDISONLEARNING via BLANK ROME GOVERNMENT RELATIONS
2012 · third_quarter · Q3
Issues related to the Elementary and Secondary Education Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHILADELPHIA MURAL ARTS ADVOCATES via BLANK ROME GOVERNMENT RELATIONS
2012 · third_quarter · Q3
Issues related to arts advocacy
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
PHILADELPHIA MURAL ARTS ADVOCATES via BLANK ROME GOVERNMENT RELATIONS
2012 · second_quarter · 2A
Issues related to arts advocacy
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
EXPEDIA, INC. via BLANK ROME GOVERNMENT RELATIONS
2012 · second_quarter · Q2
Competition in the internet search market
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
General tax issues Issues related to corporate inversions
FY 2015 State and Foreign Operations Appropriations; issues related to President's Emergency Plan For AIDS Relief (PEPFAR)/Global Fund (H.R.5013/S.2499); FY 2015 Agriculture and FDA Appropriations (H.R.4800/S.2389)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S.214, Preserve Access to Affordable Generics Act S.1720, Patent Transparency and Improvements Act of 2013 S.1013, Patent Abuse Reduction Act of 2013
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Pharmaceutical Distribution Supply Chain Security (H.R. 1919 / S. 957 / S. 959); Electronic distribution of prescribing information; School Access to Emergency Epinephrine (H.R. 2094); Biosimilars; H.R. 8; H.R. 486 - the Stop Tampering of Prescription Pills (STOPP) Act; S.504 - Fair and Immediate Release of Generic Drugs Act; S.621 - The Safe Prescribing Act of 2013 /H.R.1285 H.R.460 - Patients Access to Treatments Act of 2013
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PEPFAR Stewardship and Oversight Act of 2013 (S. 1545 / H.R. 3177)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S. 867 - Issues related to Pharmacy Benefit Managers (PBM) activities around disclosures and audit protections.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S. 214, Preserve Access to Affordable Generics Act
PEPFAR Stewardship and Oversight Act of 2013 (S. 1545 / H.R. 3177)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Pension Reform Issues
Issues related to waste management H.R. 2218: The Coal Residuals Reuse and Management Act of 2013
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PEPFAR Stewardship and Oversight Act of 2013 (S. 1545 / H.R. 3177)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to renewable energy and natural gas tax incentives S. 795/H.R. 1696: The Master Limited Partnerships Parity Act
Issues relating to bio-gas H.R. 1947: The Farm Bill, specifically Title IX, which provides funding for biofuels, energy-efficiency programs in rural areas, and the development of biochemicals and bioplastics industries. Issues relating to the renewable fuel standard
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to bio-gas H.R. 1947: The Farm Bill, specifically Title IX, which provides funding for biofuels, energy-efficiency programs in rural areas, and the development of biochemicals and bioplastics industries.
Pension Reform Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PEPFAR Stewardship and Oversight Act of 2013 (S. 1545 / H.R. 3177)
S. 214, Preserve Access to Affordable Generics Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to renewable energy and natural gas tax incentives S. 795/H.R. 1696: The Master Limited Partnerships Parity Act
Issues related to waste management H.R. 2218: The Coal Residuals Reuse and Management Act of 2013
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to requiring Pharmacy Benefit Managers annual reporting to Part D plan sponsors of number and total cost of prescriptions under a contract, payments to pharmacies, payments from pharmaceuticals manufacturers and generic and brand name drugs dispensed.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE